These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35250225)

  • 61. Research Achievements of Oral Submucous Fibrosis: Progress and Prospect.
    Xu H; Lyu FY; Song JY; Xu YM; Jiang EH; Shang ZJ; Chen LL; Xu Z
    Biomed Res Int; 2021; 2021():6631856. PubMed ID: 33791368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proposed clinical classification for oral submucous fibrosis.
    More CB; Das S; Patel H; Adalja C; Kamatchi V; Venkatesh R
    Oral Oncol; 2012 Mar; 48(3):200-2. PubMed ID: 22070918
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Morphometric analysis in potentially malignant head and neck lesions: oral submucous fibrosis.
    Singh M; Chaudhary AK; Pandya S; Debnath S; Singh M; Singh PA; Mehrotra R
    Asian Pac J Cancer Prev; 2010; 11(1):257-60. PubMed ID: 20593967
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of topical tulsi (
    Biswas D; Naik Z; Kumar SL; Patil N; Bagewadi A
    Indian J Dent Res; 2022; 33(2):146-151. PubMed ID: 36254950
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Socio-Economic Implications Of A Younger Aged Female Predilection In Malignant Transformation Of Oral Sub Mucous Fibrosis.
    Fatima N; Mohiuddin S; Hosein S; Mervyn M
    J Ayub Med Coll Abbottabad; 2019; 31(1):16-20. PubMed ID: 30868776
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral submucous fibrosis: A clinico-histopathological correlational study.
    Biradar SB; Munde AD; Biradar BC; Shaik SS; Mishra S
    J Cancer Res Ther; 2018; 14(3):597-603. PubMed ID: 29893325
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of Gustatory Function in Oral Submucous Fibrosis Patients and Gutka Chewers.
    Bangi BB; Ginjupally U; Nadendla LK; Mekala MR; B JL; Kakumani A
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):569-573. PubMed ID: 30803222
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Myofibroblasts could be recruited in a chemokine (C-C motif) ligand 2-dependent manner in pathogenesis of oral submucous fibrosis.
    Sarode G; Sarode SC; Deshmukh R; Raktade P; Patil S
    J Oral Pathol Med; 2017 Jul; 46(6):443-447. PubMed ID: 28029690
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of oral submucous fibrosis: an overview.
    Angadi PV; Rao S
    Oral Maxillofac Surg; 2010 Sep; 14(3):133-42. PubMed ID: 20177949
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative study of clinicofunctional staging of oral submucous fibrosis with qualitative analysis of collagen fibers under polarizing microscopy.
    Ceena DE; Bastian TS; Ashok L; Annigeri RG
    Indian J Dent Res; 2009; 20(3):271-6. PubMed ID: 19884707
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oral submucous fibrosis.
    O'Riordan BC
    Proc R Soc Med; 1974 Sep; 67(9):876-8. PubMed ID: 4431799
    [No Abstract]   [Full Text] [Related]  

  • 72. Silver-binding nucleolar organizer region proteins as a possible prognostic indicator in oral submucous fibrosis.
    Rajendran R; Nair SM
    Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):481-6. PubMed ID: 1408025
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surgical management of oral submucous fibrosis using buccal fat pad: a retrospective study of 30 cases.
    Thukral H; Roy Chowdhury SK; Nagori SA
    Oral Maxillofac Surg; 2018 Dec; 22(4):403-408. PubMed ID: 30238329
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
    Shieh DH; Chiang LC; Shieh TY
    Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of Ki-67 Expression in Oral Submucous Fibrosis and Its Correlation with Clinical and Histopathological Features.
    Iqbal A; Tamgadge S; Tamgadge A; Pereira T; Kumar S; Acharya S; Jadhav A
    J Microsc Ultrastruct; 2020; 8(1):20-24. PubMed ID: 32166060
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative Evaluation of SMAD-2 Expression in Oral Submucous Fibrosis and Reactive Oral Lesions.
    Zagabathina S; Ramadoss R; Ah HP; Krishnan R
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):399-403. PubMed ID: 32102517
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of Efficacy of Curcumin along with Lycopene and Piperine in the Management of Oral Submucous Fibrosis.
    Mahato B; Prodhan C; Mandal S; Dutta A; Kumar P; Deb T; Jha T; Chaudhuri K
    Contemp Clin Dent; 2019; 10(3):531-541. PubMed ID: 32308333
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correlation of addictive factors, human papilloma virus infection and histopathology of oral submucous fibrosis.
    Mehrotra R; Chaudhary AK; Pandya S; Debnath S; Singh M; Singh M
    J Oral Pathol Med; 2010 Jul; 39(6):460-4. PubMed ID: 20070487
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Current protocols in the management of oral submucous fibrosis: An update.
    Arakeri G; Rai KK; Boraks G; Patil SG; Aljabab AS; Merkx MAW; Carrozzo M; Brennan PA
    J Oral Pathol Med; 2017 Jul; 46(6):418-423. PubMed ID: 28391602
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of oxitard capsules in the treatment of oral submucous fibrosis.
    Patil S; Santosh BS; Maheshwari S; Deoghare A; Chhugani S; Rajesh PR
    J Cancer Res Ther; 2015; 11(2):291-4. PubMed ID: 26148587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.